April 10, 2019
EdiGENE Raises $15 Million in Series B Funding
TOKYO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announced…